3,009 results match your criteria: "Heart Research Institute[Affiliation]"

Improving Breast Cancer Outcomes for Indigenous Women in Australia.

Cancers (Basel)

April 2024

Djurali Centre for Aboriginal and Torres Strait Islander Research and Education, Heart Research Institute, Sydney, NSW 2042, Australia.

In Australia, the incidence rate of breast cancer is lower in Indigenous* women than non-Indigenous women; however, the mortality rate is higher, with Indigenous women 1.2 times more likely to die from the disease. This paper provides practical and achievable solutions to improve health outcomes for Indigenous women with breast cancer in Australia.

View Article and Find Full Text PDF

Co-designing policy with Aboriginal and Torres Strait Islander peoples: a protocol.

Public Health Res Pract

October 2024

Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia; Djurali Centre for Aboriginal and Torres Strait Islander Health Research and Education, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia; Heart Research Institute (HRI), Sydney, NSW, Australia.

Objectives and importance of study: In the public service context, co-design is novel and ever-expanding. Co-design brings together decision-makers and people impacted by a problem to unpack the problem and design solutions together. Government agencies are increasingly adopting co-design to understand and meet the unique needs of priority populations.

View Article and Find Full Text PDF

Development of supramolecular anticoagulants with on-demand reversibility.

Nat Biotechnol

April 2024

Department of Organic Chemistry, NCCR Chemical Biology, Faculty of Sciences, University of Geneva, Geneva, Switzerland.

Drugs are administered at a dosing schedule set by their therapeutic index, and termination of action is achieved by clearance and metabolism of the drug. In some cases, such as anticoagulant drugs or immunotherapeutics, it is important to be able to quickly reverse the drug's action. Here, we report a general strategy to achieve on-demand reversibility by designing a supramolecular drug (a noncovalent assembly of two cooperatively interacting drug fragments held together by transient hybridization of peptide nucleic acid (PNA)) that can be reversed with a PNA antidote that outcompetes the hybridization between the fragments.

View Article and Find Full Text PDF

Aims: To determine the roles of matrix metallopeptidase-9 (MMP9) on human coronary artery smooth muscle cells (HCASMCs) , early beginning of atherosclerosis in diabetic mice, and drug naïve patients with diabetes.

Methods: Active human MMP9 (act-hMMP9) was added to HCASMCs and the expressions of MCP-1, ICAM-1, and VCAM-1 were measured. Act-hMMP9 (n=16) or placebo (n=15) was administered to diabetic KK.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how serial measurements of NT-proBNP, a heart failure biomarker, relate to cardiac changes and patient outcomes, considering various clinical factors.
  • Analysis involved 1911 heart failure patients, revealing that NT-proBNP levels generally declined, especially in certain groups like inpatients and those on guideline-recommended medications.
  • An increase in NT-proBNP over time was linked to a higher risk of hospitalization or death, with variations noted based on patient age, atrial fibrillation presence, and heart failure types.
View Article and Find Full Text PDF

A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.

Eur J Heart Fail

April 2024

Department of Translational Medical Sciences, Interdepartmental Center for Clinical and Translational Research (CIRCET), and Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.

Article Synopsis
  • Pulmonary hypertension (PH) linked to left heart failure (PH-LHF) is a common condition that worsens symptoms, reduces physical ability, and harms right heart function, leading to a poor outlook for patients.
  • Despite various drugs being tested, there are currently no specific treatments for PH-LHF, highlighting significant gaps in understanding its pathophysiology and clinical management.
  • The document calls for improved research on pulmonary venous changes, patient categorization for tailored therapies, and rigorous pre-clinical studies to enhance clinical trials and expand treatment options beyond current methods used for pulmonary arterial hypertension.
View Article and Find Full Text PDF

There is a need for new treatments to reduce brain injuries derived from neonatal hypoxia/ischemia. The only viable option used in the clinic today in infants born at term is therapeutic hypothermia, which has a limited efficacy. Treatments with exogenous RNase have shown great promise in a range of different adult animal models including stroke, ischemia/reperfusion injury, or experimental heart transplantation, often by conferring vascular protective and anti-inflammatory effects.

View Article and Find Full Text PDF

Background: Growth hormone (GH) resistance is characterized by high GH levels but low levels of insulin-like growth factor-I (IGF-I) and growth hormone binding protein (GHBP) and, for patients with chronic disease, is associated with the development of cachexia.

Objectives: We investigated whether GH resistance is associated with changes in left ventricular (LV) mass (cardiac wasting) in patients with cancer.

Methods: We measured plasma IGF-I, GH, and GHBP in 159 women and 148 men with cancer (83% stage III/IV).

View Article and Find Full Text PDF

The Effect of Community-Based Exercise on Health Outcomes for Indigenous Peoples with Type 2 Diabetes: A Systematic Review.

Int J Environ Res Public Health

March 2024

Djurali Centre for Aboriginal and Torres Strait Islander Health Research, Heart Research Institute, Eliza Street, Newtown, NSW 2042, Australia.

Indigenous peoples globally experience a high burden of type 2 diabetes in comparison to non-Indigenous peoples. While community-based exercise interventions designed for type 2 diabetes (T2D) management have garnered success in non-Indigenous populations, they likely require adjustments to meet the needs of Indigenous people. This systematic review aims to determine if health outcomes in Indigenous peoples with T2D could be improved by community-based exercise programmes and the features of those programmes that best meet their needs.

View Article and Find Full Text PDF

Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction.

JACC Heart Fail

May 2024

Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia; University of Sydney, Faculty of Medicine and Health, Sydney, New South Wales, Australia; Heart Research Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. Electronic address:

Background: The independent effect of pulmonary hypertension (PHT) severity on mortality in those with reduced left ventricular ejection fraction (LVEF) is not well known.

Objectives: The authors aimed to examine the prognostic impact of increasingly elevated pulmonary pressures in a large clinical cohort of adults with reduced LVEF.

Methods: The authors analyzed data from the National Echocardiography Database of Australia, a large clinical registry linking routine echocardiographic investigations to mortality.

View Article and Find Full Text PDF

Aims: Recent guidelines recommend four core drug classes (renin-angiotensin system inhibitor/angiotensin receptor-neprilysin inhibitor [RASi/ARNi], beta-blocker, mineralocorticoid receptor antagonist [MRA], and sodium-glucose cotransporter 2 inhibitor [SGLT2i]) for the pharmacological management of heart failure (HF) with reduced ejection fraction (HFrEF). We assessed physicians' perceived (i) comfort with implementing the recent HFrEF guideline recommendations; (ii) status of guideline-directed medical therapy (GDMT) implementation; (iii) use of different GDMT sequencing strategies; and (iv) barriers and strategies for achieving implementation.

Methods And Results: A 26-question survey was disseminated via bulletin, e-mail and social channels directed to physicians with an interest in HF.

View Article and Find Full Text PDF

Aims: Turbulent aortic flow makes the cardiovascular system less effective. It remains unknown if patients with heart failure with preserved ejection fraction (HFpEF) have disturbed aortic flow. This study sought to investigate advanced markers of aortic flow disturbances in HFpEF.

View Article and Find Full Text PDF

Background: Pulmonary artery (PA) strain is associated with structural and functional alterations of the vessel and is an independent predictor of cardiovascular events. The relationship of PA strain to metabolomics in participants without cardiovascular disease is unknown.

Methods: In the current study, community-based older adults, without known cardiovascular disease, underwent simultaneous cine cardiovascular magnetic resonance (CMR) imaging, clinical examination, and serum sampling.

View Article and Find Full Text PDF

Post-translational modifications (PTMs) are crucial mechanisms that underlie the intricacies of biological systems and disease mechanisms. This review focuses on the latest advancements in the design of heterobifunctional small molecules that hijack PTM machineries for target-specific modifications in living systems. A key innovation in this field is the development of proteolysis-targeting chimeras (PROTACs), which promote the ubiquitination of target proteins for proteasomal degradation.

View Article and Find Full Text PDF

Coronary artery stents are life-saving devices, and millions of these devices are implanted annually to treat coronary heart disease. The current gold standard in treatment is drug-eluting stents, which are coated with a biodegradable polymer layer that elutes antiproliferative drugs to prevent restenosis due to neointimal hyperplasia. Stenting is commonly paired with systemic antiplatelet therapy to prevent stent thrombosis.

View Article and Find Full Text PDF

Current Practices and Attitudes of Cardiac Nurses Regarding Cognitive Screening in Patients With Acute Coronary Syndrome.

Heart Lung Circ

July 2024

Charles Perkins Centre & Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

Background: Cognitive impairment (CI) is common in patients with acute coronary syndrome (ACS) but is often undetected and may affect recovery and secondary prevention uptake. Nurses play a crucial role providing care for patients with ACS and promoting secondary prevention.

Aim: This study aimed to explore current nursing practices and barriers regarding CI screening in patients with ACS.

View Article and Find Full Text PDF

Exercise-based cardiac rehabilitation for adults with heart failure.

Cochrane Database Syst Rev

March 2024

MRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics, Institute of Health and Well Being, University of Glasgow, Glasgow, UK.

Article Synopsis
  • People with heart failure face significant challenges including low exercise tolerance, poor quality of life, increased hospital admissions, and high healthcare costs; exercise-based cardiac rehabilitation (ExCR) has shown potential benefits in these areas according to a 2018 review.
  • The objectives of the new review were to evaluate the effects of ExCR on mortality, hospital admissions, and health-related quality of life among adults with heart failure.
  • The study included randomized controlled trials that compared ExCR interventions to no exercise control, focusing on patients with both heart failure with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF).
View Article and Find Full Text PDF

Financial Aid in Children, Adolescents and Young Adult's Cancer Care: A Scoping Review.

J Adolesc Young Adult Oncol

August 2024

Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia.

The financial burden resulting from cancers on families is higher when it arises in young people compared with older adults. Previous research has provided insight into the financial toxicities associated with childhood cancer, but less is known about the efficacy of financial aid systems in reducing the financial burden on families. We conducted a scoping review to identify the determinants of success and failure of financial aid.

View Article and Find Full Text PDF
Article Synopsis
  • P2Y12 inhibitor monotherapy is being explored as a shorter, effective alternative to dual antiplatelet therapy (DAPT) for patients who have undergone percutaneous coronary intervention (PCI) with drug-eluting stents.
  • The SHARE trial aimed to compare the safety and efficacy of switching to P2Y12 inhibitor monotherapy after 3 months of DAPT against continuing DAPT for a full 12 months.
  • The study involved 1,387 patients across 20 hospitals in South Korea, monitoring outcomes like major bleeding and adverse cardiac events over the course of a year to determine if the shorter therapy was just as safe.
View Article and Find Full Text PDF
Article Synopsis
  • Heart failure (HF) and diabetes worsen each other’s outcomes, and this study evaluated global longitudinal strain (GLS) as a prognostic marker in HF patients with diabetes.
  • In a study of 315 HF patients, those with diabetes showed significantly worse cardiovascular indicators, such as higher late gadolinium enhancement rates and elevated biomarker levels compared to non-diabetic patients.
  • The results indicated that patients with diabetes not only had poorer health indicators but also a worse prognosis, with GLS and soluble ST2 biomarkers emerging as independent prognostic factors for adverse outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • * The occurrence of hyperkalaemia in HF patients varies significantly based on factors like disease severity and medication, with rates ranging from 7% to 39%.
  • * Despite guidelines for monitoring serum potassium levels, a large percentage of patients (55-93%) do not receive adequate testing, highlighting a need for more comprehensive international research on this issue. *
View Article and Find Full Text PDF

New-onset hypertension as a contributing factor to the incidence of atrial fibrillation in the elderly.

Hypertens Res

June 2024

Department of Cardiovascular Medicine, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Hypertension and atrial fibrillation are closely related. However, hypertension is already prevalent in young adults, but atrial fibrillation usually occurs in the elderly. In the present analysis, we investigated incident atrial fibrillation in relation to new-onset hypertension in an elderly Chinese population.

View Article and Find Full Text PDF

A large variety of dietary phytochemicals has been shown to improve thrombosis and stroke outcomes in preclinical studies. Many of these compounds feature electrophilic functionalities that potentially undergo covalent addition to the sulfhydryl side chain of cysteine residues within proteins. However, the impact of such covalent modifications on the platelet activity and function remains unclear.

View Article and Find Full Text PDF